Point Of Care Lipid Test Market Report 2026

Point Of Care Lipid Test Market Overview

• Point Of Care Lipid Test market size has reached to $0.74 billion in 2025 • Expected to grow to $1.17 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Increasing Prevalence Of Cardiovascular Diseases Fueling The Growth Of The Market Due To Rising Need For Early Detection And Timely Intervention • Market Trend: Enhancing Clinical Decision-Making And Patient Management Through Advanced Diagnostic Platforms • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Point Of Care Lipid Test Market?

A point of care lipid test is a quick diagnostic test that uses a fingerstick blood sample to detect cholesterol and triglyceride levels without sending the samples to a central laboratory. It delivers fast data to help with cardiovascular risk assessment and continued monitoring. The main product types of point of care lipid tests are instruments, consumables, and others. Instruments refer to portable analyzers and testing devices designed to rapidly assess lipid profiles such as cholesterol and triglyceride levels at or near the site of patient care. These solutions are used in various applications such as hyperlipidemia, hypertriglyceridemia, Tangier disease, hyperlipoproteinemia, familial hypercholesterolemia, and others, and the key end-users are hospitals, clinics, diagnostic laboratories, home care settings, and others.

What Is The Point Of Care Lipid Test Market Growth Forecast?

The point of care lipid test market size is expected to see strong growth in the next few years. It will grow to $1.17 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to integration with mobile apps and cloud platforms, expansion in home care settings, adoption in clinics and hospitals, development of multi-analyte tests, collaborations between device and software providers. Major trends in the forecast period include fingerstick lipid testing, portable lipid analyzers, multi-parameter analyzers, rapid cardiovascular risk assessment, home-based lipid monitoring.

Global Point Of Care Lipid Test Market Segmentation

1) By Product Types: Instruments, Consumables 2) By Application: Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Familial Hypercholesterolemia, Other Applications 3) By End-User: Hospitals, Clinics, Home Care Settings, Other End Users Subsegments: 1) By Instruments: Portable Or Handheld Analyzers, Multi-parameter Analyzers, Single-parameter Analyzers 2) By Consumables: Test Strip, Reagents And Kits

What Is The Driver Of The Point Of Care Lipid Test Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the point of care lipid test market going forward. Cardiovascular diseases refer to disorders of the heart and blood vessels, including coronary artery disease, stroke, and hypertension, often caused by atherosclerosis linked to abnormal cholesterol and triglyceride levels. The growing prevalence of cardiovascular diseases are due to rising sedentary lifestyles and reduced physical activity, which contributes to obesity, poor circulation, and other risk factors for CVDs. Point-of-care lipid tests support the management of the increasing prevalence of cardiovascular diseases by providing quick, on-site measurement of cholesterol and other lipid levels, enabling early risk identification and prompt treatment decisions to prevent disease progression. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, in the cardiovascular sector, the number of deaths due to cardiovascular disease is reaching 931,578, which represents a rise of 3,000 fatalities compared to the previous year's figure of 928,741. Therefore, the increasing prevalence of cardiovascular diseases is expected to propel the growth of the point of care lipid test industry.

Key Players In The Global Point Of Care Lipid Test Market

Major companies operating in the point of care lipid test market are Abbott Laboratories, EKF Diagnostics Holdings plc, Roche Diagnostics International AG, Siemens Healthineers AG, Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, EKF Diagnostics USA Inc., VivaChek Biotech (Hangzhou) Co. Ltd., Menarini Diagnostics S.r.l., Trinity Biotech plc, AccuBioTech Co. Ltd., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited, SD Biosensor Inc., ARKRAY Inc., PTS Diagnostics, HemoCue AB, MedTest Dx Inc., Nova Biomedical Corporation

Global Point Of Care Lipid Test Market Trends and Insights

Major companies operating in the point-of-care lipid test market are focusing on innovative solutions, such as advanced point-of-care (POC) diagnostic platforms, to deliver rapid, accurate, and lab-quality lipid panel results at the patient’s bedside, improving clinical decision-making and patient management. An advanced point-of-care (POC) diagnostic platform refers to a portable, integrated device that performs rapid, accurate, and lab-quality tests near the patient, enabling real-time clinical decision-making and immediate health management. For instance, in July 2023, Vital Biosciences Inc., a Canada-based health technology company, launched a point-of-care lab testing platform called VitalOne, designed to deliver over 50 lab-grade blood test results within just 20 minutes using a compact, automated device at sites such as clinics and pharmacies. This combines hematology, clinical chemistry, and immunoassays in a single instrument, that enables healthcare providers to perform testing, diagnosis, and treatment in a single visit, radically improving access, speed, and personalization of patient care, all with accuracy comparable to traditional central labs.

What Are Latest Mergers And Acquisitions In The Point Of Care Lipid Test Market?

In May 2023, PTS Diagnostics, a US-based manufacturer of point-of-care medical testing devices, partnered with BIOSYNEX S.A. to close gaps in care for patients with chronic disease around the world. With this collaboration, PTS Diagnostics and BIOSYNEX aim to expand their point-of-care lipid and A1C testing offerings, enhancing cardiovascular and diabetes care globally. BIOSYNEX S.A. is a France-based company. It specializes in the design, manufacture, and distribution of rapid diagnostic tests, including point-of-care lipid testing solutions.

Regional Outlook

North America was the largest region in the point of care lipid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Point Of Care Lipid Test Market?

The point of care lipid test market consists of revenues earned by entities by providing services such as lipid profile testing services, diagnostic support services, home-based testing services, and technical support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care lipid test market includes the sale of test strips, lipid panel analyzers, handheld lipid testing devices, cholesterol testing devices, multi-parameter testing devices, lancets, control solutions, reagent kits, wireless lipid testing devices, and Bluetooth-enabled lipid monitors. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.